PVmed
2022-04-18

Service round: Round A

Lead-in mechanism: Philips China

Company profile: PVmed is a domestic provider of AI enabled precision medical solutions.


Zhongze Therapeutics
2022-04-18

Service round: Pre A Round

Lead-in mechanism: Cenova Ventures

Company profile: Zhongze pharmaceutical is an innovative drug R & D enterprise focusing on the field of CNS.

LERMING PHARMA
2022-04-18

Service round: Pre A Round

Lead-in mechanism: Shandong transportation industry development fund

Company profile: Leming pharmaceutical focuses on the research, development and production of preparations in the transdermal field.

Huiyi Health
2022-04-18

Service round: Pre A Round

Lead-in mechanism: Matrix Partners China

Company profile: Huiyi health is a comprehensive service operator integrating and innovating the medical, pharmaceutical and insurance industries.

HOPSTEM BIOTECH
2022-04-18

Service round: Round B

Introducing institutions: GL Ventures,Lilly Asia Ventures,YuanBio Venture Capital 

Company profile: hode bio is an innovative R & D enterprise committed to providing stable, safe, effective and affordable IPSC cell therapy products for patients all over the world.

Igenesis
2022-04-18

Service round: Round C

Lead-in mechanism:Morningside,SunLand,Silicon Harbour

Company profile: Igenesis is the first batch of innovative high-tech medical device enterprises focusing on real-time molecular diagnosis technology in China.

KOUSAI
2022-06-27

Service round: Pre A Round

Lead-in mechanism: Fuho Capital、Hengyue Investement

Company profile: Kousai is a high-tech enterprise focusing on the field of tumor immunotherapy, mainly engaged in the R&D and industrialization of a new generation of individualized dendritic cell tumor vaccines (DC vaccines).


Ashermed
2022-06-27

Service round: Round B

Lead-in mechanism: Qiming Venture Partners、Daohe、ScoreCapital

Company profile: Ashermed is an innovative digital clinical CRO company that focuses on providing post-market clinical research, academic marketing, patient management and related technology research and development for domestic and foreign innovative pharmaceutical and device companies.

Grentsun
2022-06-29

Service round: Round A
Lead-in mechanism: Longyuhongda、Guoxinhaixiang、Henan Jinggang Equity Investment Fund
Company profile: Grentsun is a leading innovative technology-based drug research and development enterprise in China.

HQ Pharma
2025-12-31

Round: Equity acquisition

Company profile: Founded in 2017, HQ Pharma is a pharmaceutical R&D company specializing in improved new drugs and complex formulations, and can provide full-process R&D services covering pharmaceutical research, clinical trials and regulatory filings.